Ergothioneine as a Protective Agent Against Age-Related Diseases: Issues Needing More Research

preprint OA: closed CC-BY-4.0
🔓 Open OA copy View at publisher

Abstract

Ergothioneine (ET) is a diet-derived compound that is avidly absorbed and retained by the human body using a specialised transporter, OCTN1. A substantial and growing body of evidence implicates ET in maintaining human health and protecting against age-related diseases, especially neurodegenerative diseases, and multiple studies indicate that low blood ET levels increase the risk of developing age-related diseases. Despite the growing interest in ET, much fundamental work remains to be done on its metabolism, intracellular and intercellular transport (especially in the brain), precise mechanisms of cytoprotection, interactions with the microbiome, mycobiome and human pathogens, and identifying the factors that control body ET levels. This narrative review explores these issues and suggests what research needs to be done to improve our understanding of ET biology.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-06-06T02:00:05.402940+00:00
License: CC-BY-4.0